BioPact
Associate Sponsor
Biopact CT has developed MGMR™, a unique non-biologic next generation transfection technology. This heavily patented and versatile intracellular delivery vehicle uses discrete hollow, nanoscale tubules approximately 1/10,000th the width of a human hair. The high aspect-ratio, nanoscale profile of MGMR™ allows it to readily penetrate cells without compromising membrane integrity or inducing cytotoxicity. Its high surface-to-volume ratio and tunable surface chemistry allow it to transport both small and large-molecular cargos into the cytoplasm, including oligonucleotides, peptides, proteins and genetic materials, vector and genetic materials.
